Eberhard Karls Universitt Tbingen competitive analysis

Explore Eberhard Karls Universitt Tbingen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Mar 26, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 4, 2020Methods And Substances For Directed Rna Editing1
Dec 4, 2019Permanent Gene Correction By Means Of Nucleotide-Modified Messenger Rna1
Sep 11, 2019Fusion Proteins Comprising A Binding Protein And An Interleukin-15 Polypeptide Having A Reduced Affinity For Il15Ra And Therapeutic Uses Thereof2

Latest PTAB cases involving Eberhard Karls Universitt Tbingen

Discover the latest PTAB cases involving Eberhard Karls Universitt Tbingen, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Eberhard Karls Universitt Tbingen with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Mar 26, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
EBERHARD KARLS UNIVERSITT TBINGEN - 3 - -
MARGARET DIXON60 - - -
PFIZER53944412